QQQ   437.82 (+0.24%)
AAPL   180.77 (-0.96%)
MSFT   408.77 (-0.38%)
META   484.39 (+0.07%)
GOOGL   138.11 (-4.06%)
AMZN   174.77 (-0.13%)
TSLA   199.68 (+4.02%)
NVDA   800.33 (+1.54%)
NIO   5.58 (+3.33%)
AMD   176.73 (+0.12%)
BABA   76.29 (+0.43%)
T   16.61 (-1.13%)
F   12.07 (-0.58%)
MU   91.20 (+6.05%)
CGC   3.45 (+2.68%)
GE   154.57 (+0.81%)
DIS   107.91 (+0.16%)
AMC   4.57 (+2.93%)
PFE   27.12 (-2.31%)
PYPL   59.46 (+0.51%)
XOM   104.58 (+0.71%)
QQQ   437.82 (+0.24%)
AAPL   180.77 (-0.96%)
MSFT   408.77 (-0.38%)
META   484.39 (+0.07%)
GOOGL   138.11 (-4.06%)
AMZN   174.77 (-0.13%)
TSLA   199.68 (+4.02%)
NVDA   800.33 (+1.54%)
NIO   5.58 (+3.33%)
AMD   176.73 (+0.12%)
BABA   76.29 (+0.43%)
T   16.61 (-1.13%)
F   12.07 (-0.58%)
MU   91.20 (+6.05%)
CGC   3.45 (+2.68%)
GE   154.57 (+0.81%)
DIS   107.91 (+0.16%)
AMC   4.57 (+2.93%)
PFE   27.12 (-2.31%)
PYPL   59.46 (+0.51%)
XOM   104.58 (+0.71%)
QQQ   437.82 (+0.24%)
AAPL   180.77 (-0.96%)
MSFT   408.77 (-0.38%)
META   484.39 (+0.07%)
GOOGL   138.11 (-4.06%)
AMZN   174.77 (-0.13%)
TSLA   199.68 (+4.02%)
NVDA   800.33 (+1.54%)
NIO   5.58 (+3.33%)
AMD   176.73 (+0.12%)
BABA   76.29 (+0.43%)
T   16.61 (-1.13%)
F   12.07 (-0.58%)
MU   91.20 (+6.05%)
CGC   3.45 (+2.68%)
GE   154.57 (+0.81%)
DIS   107.91 (+0.16%)
AMC   4.57 (+2.93%)
PFE   27.12 (-2.31%)
PYPL   59.46 (+0.51%)
XOM   104.58 (+0.71%)
QQQ   437.82 (+0.24%)
AAPL   180.77 (-0.96%)
MSFT   408.77 (-0.38%)
META   484.39 (+0.07%)
GOOGL   138.11 (-4.06%)
AMZN   174.77 (-0.13%)
TSLA   199.68 (+4.02%)
NVDA   800.33 (+1.54%)
NIO   5.58 (+3.33%)
AMD   176.73 (+0.12%)
BABA   76.29 (+0.43%)
T   16.61 (-1.13%)
F   12.07 (-0.58%)
MU   91.20 (+6.05%)
CGC   3.45 (+2.68%)
GE   154.57 (+0.81%)
DIS   107.91 (+0.16%)
AMC   4.57 (+2.93%)
PFE   27.12 (-2.31%)
PYPL   59.46 (+0.51%)
XOM   104.58 (+0.71%)
NASDAQ:BIAFW

bioAffinity Technologies (BIAFW) Stock Price, News & Analysis

$0.20
+0.08 (+70.94%)
(As of 02/23/2024 03:55 PM ET)
Today's Range
$0.12
$0.20
50-Day Range
$0.05
$0.20
52-Week Range
$0.05
$0.70
Volume
3,600 shs
Average Volume
3,177 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIAFW stock logo

About bioAffinity Technologies Stock (NASDAQ:BIAFW)

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

BIAFW Stock Price History

BIAFW Stock News Headlines

bioAffinity Technologies (NASDAQ:BIAFW) Trading 70.9% Higher
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
bioAffinity Technologies Inc. Wt
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
bioAffinity Technologies, Inc. Warrant (BIAFW)
See More Headlines
Receive BIAFW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:BIAFW
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$321,489.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Steven Girgenti (Age 78)
    Founder & Executive Chairman of the Board
    Comp: $93.33k
  • Ms. Maria Zannes J.D. (Age 68)
    Founder, President, CEO & Director
    Comp: $260.81k
  • Dr. Vivienne I. Rebel M.D. (Age 59)
    Ph.D., Executive VP and Chief Medical & Science Officer
    Comp: $238.39k
  • Mr. Michael Dougherty CPA (Age 46)
    M.B.A., VP & CFO
  • Mr. Xavier T. Reveles M.S. (Age 55)
    Chief Operating Officer
  • Mr. Timothy P. Zannes J.D. (Age 71)
    Executive VP, Secretary & General Counsel
  • Ms. Julie Anne Overton
    Director of Communications
  • Mr. Dallas J. Coleman
    National Director of Sales
  • Dr. William Bauta Ph.D.
    Senior Vice President of Therapeutics














BIAFW Stock Analysis - Frequently Asked Questions

How have BIAFW shares performed in 2024?

bioAffinity Technologies' stock was trading at $0.0860 at the start of the year. Since then, BIAFW shares have increased by 132.6% and is now trading at $0.20.
View the best growth stocks for 2024 here
.

How do I buy shares of bioAffinity Technologies?

Shares of BIAFW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIAFW) was last updated on 2/26/2024 by MarketBeat.com Staff